BHWM
CORT icon

Bay Harbor Wealth Management’s Corcept Therapeutics CORT Stock Holding History

Bay Harbor Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$208 – 1311
2025
Q4 		$208 Sell
6
-1
-14% -$79 ﹤0.01% 1110
2025
Q3 		$581 Hold
7
– – ﹤0.01% 676
2025
Q2 		$513 Buy
7
+5
+250% +$363 ﹤0.01% 634
2025
Q1 		$228 Buy
+2
New +$122 ﹤0.01% 624

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Bay Harbor Wealth Management's CORT Position: Q1 2026 in Review

Bay Harbor Wealth Management sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 6 shares — an estimated $208 sold.

Bay Harbor Wealth Management first reported a position in CORT in Q1 2025 and held it in 4 quarters. The position peaked at $581 in Q3 2025. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Bay Harbor Wealth Management reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bay Harbor Wealth Management sold 6 Corcept Therapeutics shares in Q1 2026, an estimated $208.
  • Bay Harbor Wealth Management first reported a position in Corcept Therapeutics in Q1 2025 and held it in 4 quarters.
  • Bay Harbor Wealth Management's Corcept Therapeutics position peaked at $581 in Q3 2025.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.